Intrathecal chemotherapy with liposomal ara-C (Depocyte) in leptomeningeal metastases of solid tumors: a phase III study.

Trial Profile

Intrathecal chemotherapy with liposomal ara-C (Depocyte) in leptomeningeal metastases of solid tumors: a phase III study.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Oct 2012

At a glance

  • Drugs Cytarabine (Primary)
  • Indications Breast cancer; Cancer metastases; Lung cancer
  • Focus Therapeutic Use
  • Sponsors Mundipharma International
  • Most Recent Events

    • 23 Jun 2012 Additional location (United Kingdom) added as reported by European Clinical Trials Database record.
    • 23 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top